| Moderate-to-high intensity physical exercise in patients with Alzheimer’s disease: a randomized controlled trial K Hoffmann, NA Sobol, KS Frederiksen, N Beyer, A Vogel, K Vestergaard, ... Journal of Alzheimer's Disease 50 (2), 443-453, 2016 | 366 | 2016 |
| Validity of dementia diagnoses in the Danish hospital registers TKT Phung, BB Andersen, P Høgh, LV Kessing, PB Mortensen, ... Dementia and geriatric cognitive disorders 24 (3), 220-228, 2007 | 255 | 2007 |
| Potentially reversible conditions in 1000 consecutive memory clinic patients A Hejl, P Høgh, G Waldemar Journal of Neurology, Neurosurgery & Psychiatry 73 (4), 390-394, 2002 | 222 | 2002 |
| A gender difference in the association between APOE genotype and age-related cognitive decline EL Mortensen, P Høgh Neurology 57 (1), 89-95, 2001 | 221 | 2001 |
| Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting R Bech-Azeddine, P Høgh, M Juhler, F Gjerris, G Waldemar Journal of Neurology, Neurosurgery & Psychiatry 78 (2), 157-161, 2007 | 184 | 2007 |
| APOE genotype and MRI markers of cerebrovascular disease: Systematic review and meta-analysis S Schilling, AL DeStefano, PS Sachdev, SH Choi, KA Mather, CD DeCarli, ... Neurology 81 (3), 292-300, 2013 | 182 | 2013 |
| EEG theta power is an early marker of cognitive decline in dementia due to Alzheimer’s disease CS Musaeus, K Engedal, P Høgh, V Jelic, M Mørup, M Naik, ... Journal of Alzheimer's Disease 64 (4), 1359-1371, 2018 | 154 | 2018 |
| Effect of aerobic exercise on physical performance in patients with Alzheimer's disease NA Sobol, K Hoffmann, KS Frederiksen, A Vogel, K Vestergaard, ... Alzheimer's & Dementia 12 (12), 1207-1215, 2016 | 120 | 2016 |
| Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus. E Tedeschi, SG Hasselbalch, G Waldemar, M Juhler, P Høgh, S Holm, ... Journal of Neurology, Neurosurgery & Psychiatry 59 (6), 608-615, 1995 | 120 | 1995 |
| Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate P Hùgh, A Oturai, K Schreiber, M Blinkenberg, OS Jùrgensen, L Ryder, ... Multiple Sclerosis Journal 6 (4), 226-230, 2000 | 100 | 2000 |
| Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma CS Jensen, JM Bahl, LB Østergaard, P Høgh, L Wermuth, A Heslegrave, ... Experimental gerontology 121, 91-98, 2019 | 95 | 2019 |
| Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment P Høgh, SJ Smith, RI Scahill, D Chan, RJ Harvey, NC Fox, MN Rossor Neurology 58 (2), 298-301, 2002 | 91 | 2002 |
| Idiopathic normal‐pressure hydrocephalus: evaluation and findings in a multidisciplinary memory clinic R Bech‐Azeddine, G Waldemar, GM Knudsen, P Høgh, P Bruhn, ... European journal of neurology 8 (6), 601-611, 2001 | 90 | 2001 |
| Change in fitness and the relation to change in cognition and neuropsychiatric symptoms after aerobic exercise in patients with mild Alzheimer’s disease NA Sobol, CH Dall, P Høgh, K Hoffmann, KS Frederiksen, A Vogel, ... Journal of Alzheimer's Disease 65 (1), 137-145, 2018 | 85 | 2018 |
| White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. G Waldemar, P Christiansen, HB Larsson, P Høgh, H Laursen, NA Lassen, ... Journal of Neurology, Neurosurgery & Psychiatry 57 (12), 1458-1465, 1994 | 78 | 1994 |
| Quantitative EEG applying the statistical recognition pattern method: a useful tool in dementia diagnostic workup K Engedal, J Snaedal, P Hoegh, V Jelic, B Bo Andersen, M Naik, ... Dementia and geriatric cognitive disorders 40 (1-2), 1-12, 2015 | 70 | 2015 |
| Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise CS Jensen, AH Simonsen, V Siersma, N Beyer, KS Frederiksen, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 67 | 2019 |
| Use of flutemetamol f 18–labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment DA Wolk, C Sadowsky, B Safirstein, JO Rinne, R Duara, R Perry, ... JAMA neurology 75 (9), 1114-1123, 2018 | 62 | 2018 |
| A multidisciplinary memory clinic in a neurological setting: diagnostic evaluation of 400 consecutive patients P Høgh, G Waldemar, GM Knudsen, P Bruhn, H Mortensen, ... European Journal of Neurology 6 (3), 279-288, 1999 | 59 | 1999 |
| Cerebrospinal fluid/plasma albumin ratio as a biomarker for blood-brain barrier impairment across neurodegenerative dementias CS Musaeus, HS Gleerup, P Høgh, G Waldemar, SG Hasselbalch, ... Journal of Alzheimer's Disease 75 (2), 429-436, 2020 | 58 | 2020 |
